Clinical trials
Phase 3 trials in Iceland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
79 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 7 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 6 |
| 2009 | 8 |
| 2010 | 2 |
| 2011 | 8 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 4 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 59 |
| Terminated | 8 |
| Active, not recruiting | 7 |
| Recruiting | 2 |
| Unknown status | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 22 |
| AstraZeneca | 7 |
| Amgen | 5 |
| Novartis | 5 |
| GlaxoSmithKline | 4 |
| Janssen Research & Development, LLC | 4 |
| Hoffmann-La Roche | 3 |
| Astellas Pharma Inc | 2 |
| Lakefront Biotherapeutics NV | 2 |
| Nordic Society for Pediatric Hematology and Oncology | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Crohn Disease | 5 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 5 |
| Pulmonary Disease, Chronic Obstructive | 5 |
| Breast Neoplasms | 4 |
| Hypercholesterolemia | 4 |
| Psoriasis | 4 |
| Stroke | 4 |
| Atherosclerosis | 3 |
| Carcinoma, Non-Small-Cell Lung | 3 |
| Colitis | 3 |
Trials
Showing 1 to 25 of 79. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.